Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).
Journal: International journal of molecular sciences
Published: August 08, 2023
Insulin resistance and cardiovascular disease.
Journal: The Journal of international medical research
Published: March 30, 2023
The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease.
Journal: Diagnostics (Basel, Switzerland)
Published: January 31, 2023
Peripheral Vascular Interventions in Office-Based Laboratories: Good News for Disparities or Profit Margins?
Journal: Circulation. Cardiovascular quality and outcomes
Published: December 06, 2022
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia.
Journal: Clinical pharmacology : advances and applications
Published: March 24, 2022
New and emerging lipid-modifying drugs to lower LDL cholesterol.
Journal: Drugs in context
Published: August 05, 2021
Environmental Factors Modifying HDL Functionality.
Journal: Current medicinal chemistry
Published: February 06, 2021
Safety and Tolerability of PCSK9 Inhibitors: Current Insights.
Journal: Clinical pharmacology : advances and applications
Published: October 31, 2020
Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential.
Journal: Therapeutics and clinical risk management
Published: September 08, 2020
Role of lipoprotein (a) in peripheral arterial disease.
Journal: Annals of translational medicine
Published: October 28, 2019
Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects.
Journal: Annals of translational medicine
Published: September 27, 2019
Therapeutic management of hyperlipoproteinemia (a).
Journal: Drugs in context
Published: July 10, 2019
Last Updated: 09/26/2026